Global Plasma Therapy Market Forecast 2021-2031: By Source (Autologous, Allogenic, Other Sources) By Application (Orthopaedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, Other Applications) By Type (Pure PRP, Leucocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)) By End-User (Hospitals, Clinics & Care Centres, Research Institutes, Other End-User) Plus analysis of leading regional/national markets and leading companies in the market. COVID-19 Impact Recovery Analysis (V-shaped recovery, W-shaped recovery, U-shaped recovery, L-shaped recovery)
Visiongain’s lead analyst says: ‘The Global plasma therapy market is estimated to be valued at US $298.7 million in 2020 and is projected to reach at a market value of US$816.5 million by 2031.
Download Exclusive Sample of Report @https://www.visiongain.com/report/plasma-therapy-market-2021/#download_sampe_div
The objective is to quantify the market for blood plasma products, both the overall market as well as all the possible market segments. The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas. Also, it identifies trends, gaps, and opportunities in each micro market segment. Finally, this report identifies the major stakeholders, product portfolios, and recent developments in order to draw a competitive landscape for players in this market.
How Increased Demand for Immunoglobulins in Therapeutic Treatments is Driving the Market?
Immunoglobulins are purified and sterile products derived from blood plasma. Blood plasma market is driven by widespread acceptance of immunoglobulin-based therapies and increasing demand for subcutaneous immunoglobulin. Immunoglobulins are one of the essential components of blood plasma that contribute to the body's protection. In order to keep the immune system efficient, immunoglobulins are more commonly known as antibodies. The increase in the use of immunoglobulins in blood plasma therapy in recent years and its potential to treat various chronic illnesses can be attributed.
Is High Costs Associated with Blood Plasma Therapies Hampering the Growth?
Several emerging blood plasma therapies are widely accepted for therapeutic treatments, but their integration is expensive. For instance, the use of fresh frozen plasma (FFP) has witnessed considerable growth in recent years but has increased healthcare expenditures. FFP therapy is common in the clinical settings of U.S., but the clinical efficacy of this treatment method is a major concern. A 2019 research study performed on the cost effectiveness of FFP in therapeutic treatments indicated that the total cost per unit of fresh frozen plasma was $420, and the cost of an FFP transfusion for a single patient was $1,678. Additionally, the cost of the waste products generated during this process was 89.8% of the total cost of FFP transfusions
Leading Players featured in this market include:
Grifols International S.A
China Biologic Products Holdings, Inc.
Johnson & Johnson
Zimmer Biomet Holdings, Inc.
Thermogenesis Holdings, Inc.,
Nuo Therapeutics, Inc.,
Read this report to gain key insight into this Plasma Therapy dynamic market:
• What is the current size of the overall global human plasma therapy market? How much will this market be worth from 2021 to 2031?
• What are the main drivers and restraints that will shape the overall plasma therapy market over the next ten years?
• What are the main segments within the overall human plasma therapy market?
• How much will each of these segments be worth for the period 2021 to 2031?
• How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What is their status and how will they develop over the next ten years?
• How will political and regulatory forces influence regional markets?
• How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
• Who are the leading companies and what are their activities, results, developments and prospects?
• What are the leading plasma therapies? What are their revenues and latest developments?
• What are some of the most prominent human plasma therapy currently in development?
• How will the global plasma therapy market evolve over the forecasted period, 2021 to 2031?
• How will the market shares for each checkpoint inhibitor anti-cancer treatment submarket develop from 2021 to 2031?
• Which therapies can succeed and what revenues could they generate to 2031?
• What will be the main commercial drivers for the market from 2021 to 2031?
• How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?
To access the data contained in this document please email firstname.lastname@example.org
Plus, analysis of leading regional/national markets and Profiles of Leading Plasma Therapy Markets Companies PLUS EXCLUSIVE COVID-19 Recovery Scenarios. PLUS, EXCLUSIVE COVID-19 Recovery Scenarios.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, stayinformed with this invaluable business intelligence.
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: email@example.com
Visiongain is one of the fastest-growing and most innovative independent market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10 year forecasts, are hundreds of pages long, with in-depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which we find currently can influence one another. These markets include automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports means that you can have a bespoke piece of market intelligence customized to your very own business needs.
Commercial Director, UK
Tel: + 44 207 549 9987
Follow Us: LinkedIn | Twitter
SOURCE Visiongain Limited.